We’re investing in big data technology to analyze the growing volume and variety of data available to spark new insights into health and disease. Through data convergence, we're integrating and connecting data, resources and expertise across R&D to accelerate the discovery and development of new therapies for patients.
 

Precision medicine already plays an important role in our work, but we envision a future where it will be part of every R&D program. Our researchers are using sophisticated machine learning and artificial intelligence to illuminate predictive relationships from highly complex and multi-modal data, including clinical, molecular, and digital data. These analytical tools are giving teams a look at diseases at a digital pathology level.